XORTX Therapeutics (XRTX) Shares Outstanding (2020 - 2026)

XORTX Therapeutics' Shares Outstanding (Entity) history runs 5 years deep, the most recent figure standing at $9.7 million for Q3 2025.

• Quarterly Shares Outstanding (Entity) changed N/A year-over-year to $9.7 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $9.7 million (changed N/A YoY) and the FY2023 annual result came in at $2.9 million, up 29.04% from the prior year.
• Shares Outstanding (Entity) was $9.7 million for Q3 2025 at XORTX Therapeutics, up from $2.9 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $9.7 million in Q3 2025 and bottomed at $1.4 million in Q1 2021.
• A 4-year average of $2.8 million and a median of $2.3 million in 2022 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) jumped 57.64% — and 2023, when it increased 25.25%.
• XORTX Therapeutics' Shares Outstanding (Entity) stood at $1.7 million in 2021, then climbed by 25.6% to $2.2 million in 2022, then soared by 33.52% to $2.9 million in 2023, then jumped by 233.63% to $9.7 million in 2025.
• Business Quant data shows XRTX's Shares Outstanding (Entity) at $9.7 million in Q3 2025, $2.9 million in Q4 2023, and $3.0 million in Q3 2023.